Literature DB >> 16253089

T cells support osteoclastogenesis in an in vitro model derived from human periodontitis patients.

G Brunetti1, S Colucci, P Pignataro, M Coricciati, G Mori, N Cirulli, A Zallone, F R Grassi, M Grano.   

Abstract

BACKGROUND: Periodontitis is characterized by alveolar bone destruction; however, the mechanisms responsible for bone damage are poorly understood. It has been reported that T cells are implicated in the pathogenesis of periodontitis. It has been also demonstrated that activated T lymphocytes secrete receptor activator of nuclear factor-kappa B ligand (RANKL) and can support the differentiation of monocytes into resorbing osteoclasts (OCs). Therefore, the purpose of this study was to examine the OC formation in periodontitis patients (PP) and the role of T cells in osteoclastogenesis.
METHODS: To study OC formation, we used an in vitro model consisting of unstimulated and unfractionated peripheral blood mononuclear cells (PBMCs) from PP and controls. In parallel, T-cell-depleted PBMCs from the same patients were also established. The expression of RANKL and tumor necrosis factor-alpha (TNF-alpha) was analyzed by reverse transcription-polymerase chain reaction (RT-PCR) and Western blot in fresh T cells isolated from PP and controls. Functional antibodies, anti-RANKL and anti-TNF-alpha, were utilized to study osteoclastogenesis in PBMC cultures from PP.
RESULTS: We showed that, in unfractionated PBMCs from PP, the OCs spontaneously developed in a T-cell-dependent way. The addition of macrophage colony stimulating factor (MCSF) and RANKL was necessary to promote the osteoclastogenesis in T-cell-depleted PBMC cultures from PP and in unfractionated PBMCs from periodontally healthy controls. Moreover, freshly isolated T cells from PBMCs of PP overexpressed RANKL and TNF-alpha. Finally, functional anti-RANKL and anti-TNF-alpha antibodies significantly inhibited osteoclastogenesis.
CONCLUSION: Our data suggest that T cells support spontaneous osteoclastogenesis in PP via RANKL and TNF-alpha overexpression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16253089     DOI: 10.1902/jop.2005.76.10.1675

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  33 in total

1.  Interactions between the immune system and bone.

Authors:  Patrizia D'Amelio; Giorgia Fornelli; Ilaria Roato; Giovanni Carlo Isaia
Journal:  World J Orthop       Date:  2011-03-18

2.  Dose-specific effects of tumor necrosis factor alpha on osteogenic differentiation of mesenchymal stem cells.

Authors:  H Huang; N Zhao; X Xu; Y Xu; S Li; J Zhang; P Yang
Journal:  Cell Prolif       Date:  2011-10       Impact factor: 6.831

Review 3.  Periodontitis and bone metabolism.

Authors:  Luigi Barbato; Edoardo Francioni; Massimiliano Bianchi; Eleonora Mascitelli; Leila Brancato Marco; Duvina Paolo Tonelli
Journal:  Clin Cases Miner Bone Metab       Date:  2015-10-26

4.  A novel T cell cytokine, secreted osteoclastogenic factor of activated T cells, induces osteoclast formation in a RANKL-independent manner.

Authors:  Leonard Rifas; M Neale Weitzmann
Journal:  Arthritis Rheum       Date:  2009-11

5.  Identification of B cells participated in the mechanism of postmenopausal women osteoporosis using microarray analysis.

Authors:  Bing Yan; Jie Li; Li Zhang
Journal:  Int J Clin Exp Med       Date:  2015-01-15

6.  Low concentrations of TNF-α promote osteogenic differentiation via activation of the ephrinB2-EphB4 signalling pathway.

Authors:  Limei Wang; Jin Zhang; Cunwei Wang; Yuping Qi; Mi Du; Wenhua Liu; Chengzhe Yang; Pishan Yang
Journal:  Cell Prolif       Date:  2016-10-11       Impact factor: 6.831

Review 7.  Estrogen signaling impacts temporomandibular joint and periodontal disease pathology.

Authors:  Jennifer L Robinson; Pamela M Johnson; Karolina Kister; Michael T Yin; Jing Chen; Sunil Wadhwa
Journal:  Odontology       Date:  2019-07-03       Impact factor: 2.634

Review 8.  Macrophage immunomodulation in chronic osteolytic diseases-the case of periodontitis.

Authors:  Corneliu Sima; Ana Viniegra; Michael Glogauer
Journal:  J Leukoc Biol       Date:  2018-11-19       Impact factor: 4.962

9.  Alendronate reduces osteoclast precursors in osteoporosis.

Authors:  P D'Amelio; A Grimaldi; M A Cristofaro; M Ravazzoli; P A Molinatti; G P Pescarmona; G C Isaia
Journal:  Osteoporos Int       Date:  2009-12-01       Impact factor: 4.507

10.  Do γδ T cells predict osteonecrosis of the jaw?

Authors:  M Neale Weitzmann
Journal:  J Bone Miner Res       Date:  2013-04       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.